Model
Edge
Alnylam Pharmaceuticals, Inc.
0001226287
Filing type
4
Filing date
May 11, 2025
Updated
May 12, 2025 ยท 2:05 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership